3D QSAR in drug design. (Αριθ. εγγραφής 138031)
[ απλή προβολή ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02568cam a2200361Ia 4500 |
| 001 - CONTROL NUMBER | |
| control field | ocm51193151 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20210413130224.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cn||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 021210s2002 nyua ob 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0306468581 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780306468582 |
| Qualifying information | (electronic bk.) |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | N$T |
| Language of cataloging | eng |
| Description conventions | pn |
| Transcribing agency | N$T |
| Modifying agency | YDXCP |
| -- | OCLCG |
| -- | OCLCQ |
| -- | TUU |
| -- | OCLCQ |
| -- | TNF |
| -- | TPH |
| -- | OCLCQ |
| -- | GW5XE |
| -- | OCLCF |
| -- | OCLCQ |
| -- | AZK |
| -- | PIFBR |
| -- | UAB |
| -- | OCLCQ |
| -- | WY@ |
| -- | LUE |
| 060 #4 - National Library of Medicine Call Number | |
| Classification number | QV 744 |
| Item number | T531 2002 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615/.19 |
| Edition number | 21 |
| 245 00 - TITLE STATEMENT | |
| Title | 3D QSAR in drug design. |
| Number of part/section of a work | Volume 3, |
| Name of part/section of a work | Recent advances / |
| Statement of responsibility, etc. | edited by Hugo Kubinyi, Gerd Folkers, Yvonne C. Martin. |
| 246 3# - VARYING FORM OF TITLE | |
| Title proper/short title | Three D QSAR in drug design. |
| Number of part/section of a work | Volume 3, |
| Name of part/section of a work | Recent advances |
| 246 30 - VARYING FORM OF TITLE | |
| Title proper/short title | Recent advances |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | New York : |
| Name of publisher, distributor, etc. | Kluwer Academic, |
| Date of publication, distribution, etc. | 2002. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 ηλεκτρονική πηγή (352 σ.) : |
| Other physical details | εικ. (μερικές έγχρ.) |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references and indexes. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Volumes 2 and 3 of the 3D QSAR in Drug Design series aim to review the progress being made in CoMFA and other 3D QSAR approaches since the publication of the highly successful first volume about four years ago. Volume 2 (Ligand-Protein Interactions and Molecular Similarity) divides into three sections dealing with Ligand-Protein Interactions, Quantum Chemical Models and Molecular Dynamics Simulations, and Pharmacophore Modelling and Molecular Similarity, respectively. Volume 3 (Recent Advances) is also divided into three sections, namely 3D QSAR Methodology: CoMFA and Related Approaches, Receptor Models and Other 3D QSAR Approaches, and 3D QSAR Applications. More than seventy distinguished scientists have contributed nearly forty reviews of their work and related research to these two volumes which are of outstanding quality and timeliness. These works present an up-to-date coverage of the latest developments in all fields of 3D QSAR. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Βιοχημεία |
| 9 (RLIN) | 39 |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Φάρμακα |
| General subdivision | Σχεδιασμός |
| 9 (RLIN) | 173243 |
| 655 #0 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Ηλεκτρονικά βιβλία |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kubinyi, Hugo |
| 9 (RLIN) | 153321 |
| Relator term | επιμελητής. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Folkers, Gerd |
| 9 (RLIN) | 38222 |
| Relator term | επιμελητής. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Martin, Yvonne Connolly, |
| Dates associated with a name | 1936- |
| 9 (RLIN) | 153322 |
| Relator term | επιμελήτρια. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Title | 3D QSAR in drug design. Volume 3, Recent advances. |
| Place, publisher, and date of publication | New York : Kluwer Academic, 2002 |
| International Standard Book Number | 0792347919 |
| Record control number | <a href="(DLC) 97037816">(DLC) 97037816</a> |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=73367 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Electronic Resource |
Δεν υπάρχουν διαθέσιμα τεκμήρια.
